Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells
β Scribed by Ulrike Stein; Hermann Lage; Andreas Jordan; Wolfgang Walther; Susan E. Bates; Thomas Litman; Peter Hohenberger; Manfred Dietel
- Book ID
- 102271239
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 234 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The impact of the ABC transporters breast cancer resistance protein/mitoxantrone resistance associated transporter (BCRP/MXR), multidrug resistanceβassociated protein 1 (MRP1) and multidrug resistance geneβ1/Pβglycoprotein (MDR1/PGP) on the multidrug resistance (MDR) phenotype in chemoresistance and thermoresistance was investigated in the parental human gastric carcinoma cell line EPG85β257P, the atypical MDR subline EPG85β257RNOV, the classical MDR subline EPG85β257RDB and their thermoresistant counterparts EPG85β257PβTR, EPG85β257RNOVβTR and EPG85β257RDBβTR. Within the atypical MDR subline EPG85β257RNOV expression of BCRP/MXR and of MRP1 were clearly enhanced (vs. parental and classical MDR lines). MDR1/PGP expression was distinctly elevated in the classical MDR subline EPG85β257RDB (vs. parental and atypical MDR sublines). In all thermoresistant counterparts basal expression of BCRP/MXR, MRP1 and MDR1/PGP was increased relative to thermosensitive sublines. Although it could be shown that the overexpressed ABC transporters were functionally active, however, no decreased drug accumulations of doxorubicin, mitoxantrone and rhodamine 123 were observed. Thus, expression of BCRP/MXR, MRP1 and MDR1/PGP was found to be dependent on the appropriate type of chemoresistance; correlating with a classical or atypical MDR phenotype. Within the thermoresistant variants, however, the increase in ABC transporter expression did obviously not influence the MDR phenotype. Β© 2001 WileyβLiss, Inc.
π SIMILAR VOLUMES